Aihe Zhou
Genentech · 14 works · 947 citations · h-index 11
Top works
- Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition
- A Restricted Role for TYK2 Catalytic Activity in Human Cytokine Responses Revealed by Novel TYK2-Selective Inhibitors
- Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development
- Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 Inhibitors
- A Pentacyclic Aurora Kinase Inhibitor (AKI-001) with High in Vivo Potency and Oral Bioavailability
- Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists
- Identification of substituted 3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase
- Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in Mice
- Identification of 3,6-disubstituted dihydropyrones as inhibitors of human lactate dehydrogenase
- Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase
- Abstract DDT02-03: Discovery of GDC-0994, a potent and selective ERK1/2 inhibitor in early clinical development
- Abstract A20: Development and validation of a novel acute myeloid leukemia xenograft model that is dependent on the JAK2V617F mutation for growth in vivo
- CCDC 1583516: Experimental Crystal Structure Determination
- Structure-based optimization of hydroxylactam as potent, cell-active inhibitors of lactate dehydrogenase